-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
<>/* Style Definitions */ sp.
Shenzhen , May 27, 2022 /PRNewswire/ -- Recently, Mindray Medical stated in Interactive Yi that the medical device industry is not optional consumption, no matter in any period and in any environment, the demand for medical care is growing steadily, so , the procurement of medical devices will continue, but the needs of procurement will change with the changing environme.
For example, in the post-epidemic era, the requirements of the international market for cost-effective procurement have generally increas.
In terms of supply chain, Mindray Medical continues to promote domestic substitution of upstream raw materials and componen.
While expanding its international business, Mindray Medical has always taken compliance with the law as its bottom li.
Regarding the future development of the industry, Li Xiting, chairman of Mindray Medical, said in a letter to shareholders that the emergence of new situations and changes has not disrupted the main line of industry development, but has instead made the "Golden Decade" more adequa.
SPDB International stated in the research report that as a leader in the medical device sector and one of the few domestic medical device targets capable of involving the high-end market, Mindray fits the stock selection framework of "good track, good company, good valuation, and good timin.
